Abstract:AIM: To investigate the anti-human hepatocellular car-cinoma (HCC) activity of docetaxel and determine the potential radiosensitizing effect of docetaxel in vivo, and to further explore the mechanism of docetaxel-induced cell growth inhibition, apoptosis and radiosen-sitization at gene level.METHODS: Nude mice bearing HCC with a diameter of about 0.8 cm in the leg received 33 mg/kg docetaxel intraperitoneally, 10 Gy (5 Gy once) tumor irradiation, or both (radiation given 24 and 48 h after docetaxel treatment). The regression and regrowth of the tumors were followed until the tumor diameter reached 1.4 cm approximately. Absolute growth delay (AGD), which was defi ned as the time in days for tumors treated with docetaxel to grow from 0.8 to 1.4 cm in diameter mi-nus the time in days for untreated tumors to reach the same size, was used to evaluate the antitumor effect ofdocetaxel. Normalized growth delay (AGD), which was def ined as the time in days for tumors treated with both docetaxel and irradiation to grow from 0.8 to 1.4 cm in diameter minus the time in days for tumors treated with docetaxel alone to reach the same size, and the en-hancement factor (ratio of NGD to AGD for irradiation alone) was used to assess the effect of the combined docetaxel plus radiation treatment. Real-time qutitative reverse transcription-polymerase chain reaction (RT-PCR) was performed to detect the expression of bcl-2 and p21 genes in HCC cells before and after decetaxel treatment.RESULTS: The tumors in docetaxel treated alone and irradiation treated alone groups needed 35 and 29 d to reach 14 cm in diameter, respectively, while the ones in the control group needed 23 d. So the AGD was 12 and 6 d, respectively. The combined administra-tion of docetaxel and irradiation resulted in signifi cant growth delay (47 d), and the EF was 2.0, indicating that docetaxel enhanced tumor radioresponse. At 20 d, the sizes of the tumors in docetaxel treated alone group and combination of docetaxel and irradiation group were significantly smaller than those in the controls (P = 0.008, P = 0.005), and the size in the combination group was also smaller than that in the irradiation alone group (P = 0.002). Real time quantita-tive RT-PCR analyses revealed that mRNAs of p21 in the docetaxel treated SMMC-7721 cells at most of the time points were increased, as compared with those in the control cells. In contrast, bcl-2 expression in the docetaxel treated SMMC-7721 cells was suppressed as compared with that in the controls.CONCLUSION: Docetaxel can inhibit the growth of HCC and enhance the tumor response to fractionated irradiation in vivo by down-regulation of bcl-2 expres-sion and up-regulation of p21 expression..

Epidermal growth factor receptor blocker C225 increases chemosensitivity and radiosensitivity of Docetaxel resistant human lung adenocarcinoma cell line SPC-A-1/docetaxel

Epidermal Growth Factor Receptor Blocker C225 Increases Chemosensitivity and Radiosensitivity of Docetaxel Resistant Human Lung Adenocarcinoma Cell Line SPC-A-1/docetaxel

EGFR Inhibitor C225 Increases the Radio-Sensitivity of Human Breast Cancer Cells

EGFR Inhibitor C225 Increases the Radiosensitivity of Human Lung Squamous Cancer Cells

The effects of cetuximab in combination with docetaxel for the acquired resistance to EGFR-TKI in non-small cell lung cancer cells

Enhancement of Cetuximab on Radiosensitivity of Colorectal Cancer Cells Exposed to 125I Seeds

Combined effects of C225 and 125-iodine seed radiation on colorectal cancer cells

Inhibition Effects of Monoclonal Antibody C225 on Breast Cancer Stem Cells

Radiosensitivity of Prostate Cancer Cells is Enhanced by EGFR Inhibitor C225

Radiosensitization Effect of EGFR Inhibitor C225 on Prostate Cancer Cell

Cetuximab Affects the Capicity of DNA Repair in Colorectal Cancer Cells after 125Ⅰ Seeds Irradiation

Radiosensitization of Cetuximab on Human Tongue Cancer Cell Line Tca8113

Enhanced Cytotoxic Activity of Cetuximab in EGFR-positive Lung Cancer by Conjugating with Gold Nanoparticles

The role of EGFR MAbs C225 in breast cancer stem cells

A Experimental Study on Inhibiting Effect of Cetuximab on Angingenesis

Radiosensitizing effects of cyclooxygenase-2 selective inhibitor LM-1685 on A549 human lung adenocarcinoma cells

[Effects of Monoclonal Antibody Cetuximab on Proliferation of Non-Small Cell Lung Cancer Cell Lines].

The Antitumor Effects Of Cik Cells Combined With Docetaxel Against Drug-Resistant Lung Adenocarcinoma Cell Line Spc-A1/Dtx In Vitro And In Vivo

C6 Ceramide Dramatically Enhances Docetaxel-Induced Growth Inhibition and Apoptosis in Cultured Breast Cancer Cells: a Mechanism Study.

The mechanism of single use of monoclonal antibody C225 or combined use with DDP upon the in vitro inhibition of HeLa cells

Antitumor and radiosensitizing effect of docetaxel on human hepatocellular carcinoma and its mechanisim in vivo